Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Anavex Life Sciences Corp AVXL

Healthcare Biotechnology
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more

Recent & Breaking News (NDAQ:AVXL)

Anavex Presents Preclinical Results of ANAVEX 2-73 in Rett Syndrome

GlobeNewswire February 25, 2016

Scott + Scott, LLP Reminds Investors of Deadline to File Lead Plaintiff Papers in Anavex Life Sciences (AVXL) Securities Lawsuit

Business Wire February 23, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Anavex Life Sciences Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 29, 2016 - AVXL

PR Newswire February 23, 2016

February 29 Deadline Alert: Law Offices of Howard G. Smith Reminds Anavex Life Sciences Corp. Investors of Upcoming Lead Plaintiff Deadline

Business Wire February 22, 2016

IMPORTANT SHAREHOLDER ALERT: Scott + Scott, LLP Investigating Anavex Life Sciences (AVXL) for Possible Securities Fraud

Business Wire February 22, 2016

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Investors of Class Action Involving Anavex Life Sciences Corp. and a Lead Plaintiff Deadline of February 29, 2016 - AVXL

GlobeNewswire February 19, 2016

DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders of Anavex Life Sciences Corp. of Upcoming Deadline -- AVXL

GlobeNewswire February 19, 2016

SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Anavex Life Sciences Corp. And Reminds Investors With Losses In Excess of $250,000 To Contact The Firm

Business Wire February 17, 2016

ANAVEX 2-73 Preclinical Data in New Indication to be Presented at ACTRIMS 2016

Press Releases February 17, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Anavex Life Sciences Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 29, 2016 – AVXL

Press Releases February 16, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Anavex Life Sciences Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 29, 2016 - AVXL

GlobeNewswire February 16, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Cnova N.V. of Class Action Lawsuit and a Lead Plaintiff Deadline of March 21, 2016 – CNV

Press Releases February 16, 2016

February 29 Deadline Alert: GPM Reminds Investors of the Upcoming Lead Plaintiff Deadline in the Class Action Lawsuit against Anavex Life Sciences Corp.

Business Wire February 15, 2016

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Anavex Life Sciences Corp. of Class Action Lawsuit and Upcoming Deadline - AVXL

GlobeNewswire February 14, 2016

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Anavex Life Sciences Corp. - AVXL

GlobeNewswire February 11, 2016

IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Anavex Life Sciences Corp. and Reminds Investors with Losses in Excess of $250,000 to Contact the Firm

Business Wire February 10, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Anavex Life Sciences Corp. of Class Action Lawsuit and a Lead Plaintiff Deadline of February 29, 2016

Business Wire February 10, 2016

DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Anavex Life Sciences Corp. (AVXL) and Lead Plaintiff Deadline: February 29, 2016

Accesswire February 10, 2016

SHAREHOLDER ALERT: Lundin Law PC Announces Ongoing Investigation of Anavex Life Sciences Corp. and Urges Investors with Losses in Excess of $250,000 to Contact the Firm

Business Wire February 9, 2016

UPCOMING DEADLINE ALERT: Brower Piven Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Anavex Life Sciences Corp. to Contact Brower Piven before the Lead Plaintiff Deadline in Class Action Lawsuit

Business Wire February 8, 2016